Oral rhein attenuate nonalcoholic steatohepatitis in mice through the modulation of gut microbiota and Th17 cell differentiation
Authors:
- 13 October 2025
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 148, 157409
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China-Guangdong Joint Fund (82074344)
- National Administration of Traditional Chinese Medicine
- National Natural Science Foundation of China
- Beijing University of Chinese Medicine (NO.K2023A01)
This publication has 49 references indexed in Scilit:
- Allo-lithocholic acid, a microbiome derived secondary bile acid, attenuates liver fibrosisBiochemical Pharmacology, 2025
- Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonismBiomedicine & Pharmacotherapy, 2024
- Resmetirom: First ApprovalDrugs, 2024
- A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitisBiomedicine & Pharmacotherapy, 2024
- Faecalibacterium prausnitzii, Bacteroides faecis and Roseburia intestinalis attenuate clinical symptoms of experimental colitis by regulating Treg/Th17 cell balance and intestinal barrier integrityBiomedicine & Pharmacotherapy, 2023
- Nonalcoholic SteatohepatitisJAMA, 2020
- Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future DirectionDigestive Diseases and Sciences, 2020
- Gut–liver axis alterations in alcoholic liver disease: Are bile acids the answer?Hepatology, 2018
- Pathogenesis of nonalcoholic steatohepatitisCellular and Molecular Life Sciences, 2016
- Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2013